ZYRTECPROFESSIONAL.COM KEYWORD DENSITY CHECKER

Total words: 1700 | 2-word phrases: 444 | 3-word phrases: 486 | 4-word phrases: 503

PAGE INFO

Title Try to keep the title under 60 characters (76 characters)
Resources & Samples for Healthcare Professionals | ZYRTEC® Professional
Description Try to keep the meta description between 50 - 160 characters (167 characters)
Allow the makers of ZYRTEC® to help you provide care to your patients with allergy education and forecast tools, plus ZYRTEC® product dosage, information & more.
Keywords Meta keywords are not recommended anymore (0 characters)
H1 H1 tag on the page (8 characters)
ZYRTEC®

ONE WORD PHRASES 267 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1of145.24%
2in114.12%
3with103.75%
4and93.37%
5symptoms83.00%
6zyrtec®83.00%
7allergy72.62%
8the72.62%
9at72.62%
10on62.25%

TWO WORD PHRASES 444 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1at hour61.35%
2allergic rhinitis51.13%
3of a51.13%
4seasonal allergic40.90%
5with seasonal40.90%
6in subjects40.90%
7day jh30.68%
8on the30.68%
9first day30.68%
10itchy watery30.68%
11exposure unit30.68%
12environmental exposure30.68%
13to 2430.68%
14briscoe m30.68%
15jh briscoe30.68%
1621 to30.68%
17subjects with30.68%
18watery eyes30.68%
19runny nose30.68%
20onset of20.45%

THREE WORD PHRASES 486 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1with seasonal allergic40.82%
221 to 2430.62%
3day jh briscoe30.62%
4jh briscoe m30.62%
5in subjects with30.62%
6subjects with seasonal30.62%
7seasonal allergic rhinitis30.62%
8environmental exposure unit30.62%
9total symptom severity20.41%
10zyrtec® 10 mg20.41%
11at hours 2120.41%
12hours 21 to20.41%
13onset of action20.41%
14d kramer b20.41%
15chapman d kramer20.41%
16at hour 120.41%
17on the first20.41%
18the first day20.41%
19day of a20.41%
20hour 1 and20.41%
211 and claritin®20.41%
22pollen challenge in20.41%
23or placebo in20.41%
24of a 2day20.41%
25first dose on20.41%
26first day of20.41%
27working at hour20.41%
28based on first20.41%
29on first dose20.41%
30dose on the20.41%

FOUR WORD PHRASES 503 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1with seasonal allergic rhinitis30.60%
2day jh briscoe m30.60%
3in subjects with seasonal30.60%
4subjects with seasonal allergic30.60%
5on first dose on20.40%
6first day of a20.40%
7the first day of20.40%
8dose on the first20.40%
9first dose on the20.40%
10based on first dose20.40%
11on the first day20.40%
12chapman d kramer b20.40%
13hours 21 to 2420.40%
14at hour 1 and20.40%
15hour 1 and claritin®20.40%
16at hours 21 to20.40%
17day of a 2day20.40%
18mg at hours 2110.20%
19180 mg at hours10.20%
20allegra® 180 mg at10.20%
21primary efficacy endpoint was10.20%
22efficacy endpoint was change10.20%
23endpoint was change in10.20%
24was change in total10.20%
25total symptom severity score10.20%
26vs allegra® 180 mg10.20%
27mg vs allegra® 18010.20%
28in total symptom severity10.20%
2910 mg vs allegra®10.20%
30zyrtec® 10 mg vs10.20%
31with zyrtec® 10 mg10.20%
32study with zyrtec® 1010.20%
33change in total symptom10.20%
34skip to main content10.20%
35from baseline at hours10.20%
36the sum of selfassessed10.20%
37nose sneezing itchy nosepalatethroat10.20%
38runny nose sneezing itchy10.20%
39scores of 4 symptoms10.20%
40severity scores of 410.20%

EXTERNAL LINKS

# URL Whois Check
1https://www.kenvue.com/ Whoiskenvue.com
2https:\/\/kenvuepro.com/en-us/ Whois.
3https:\/\/kenvuepro.com/en-us/aveeno Whois.
4https:\/\/kenvuepro.com/en-us/kenvue-pediatrics Whois.
5https:\/\/kenvuepro.com/en-us/listerine Whois.
6https:\/\/kenvuepro.com/en-us/neutrogena Whois.
7https:\/\/kenvuepro.com/en-us/pepcid Whois.
8https:\/\/kenvuepro.com/en-us/zarbees Whois.
9https:\/\/kenvuepro.com/en-us/zyrtec Whois.
10https:\/\/kenvuepro.com/en-us/allergy Whois.
11https:\/\/kenvuepro.com/en-us/digestive-health Whois.
12https:\/\/kenvuepro.com/en-us/oral-health Whois.
13https:\/\/kenvuepro.com/en-us/pediatrics Whois.
14https:\/\/kenvuepro.com/en-us/skin-health Whois.
15https:\/\/kenvuepro.com/en-us/wellness Whois.
16https:\/\/kenvuepro.com/en-us/clinical-resources Whois.
17https:\/\/kenvuepro.com/en-us/patient-education Whois.
18https:\/\/kenvuepro.com/en-us/zyrtec/products Whois.
19https:\/\/kenvuepro.com/en-us/clinical-resources/seasonal-allergies#ocular-symptoms Whois.
20https:\/\/kenvuepro.com/en-us/patient-education/cold-flu-or-allergy Whois.
21https:\/\/kenvuepro.com/en-us/samples Whois.
22https:\/\/kenvuepro.com/en-us/samples Whois.
23https:\/\/kenvuepro.com/en-us/samples Whois.
24https:\/\/kenvuepro.com/en-us/zyrtec/patient-education Whois.
25https://kenvue.com Whoiskenvue.com
26https:\/\/kenvuepro.com/en-us/contact-us Whois.
27https:\/\/kenvuepro.com/en-us/legal-notice Whois.
28https://www.kenvue.com/privacy-policy/us Whoiskenvue.com
29https:\/\/kenvuepro.com/en-us/cookie-policy Whois.